Group B Streptococcus (GBS) is a leading cause of perinatal infectious diseases, particularly neonatal sepsis and meningitis. GBS is a bacterium that normally resides in the genital and gastrointestinal tracts of healthy adults, but it can be transmitted to the newborn during childbirth. In pregnant women, GBS screening is routinely performed around the 35th to 37th week of gestation to identify carriers. Infants born to GBS-positive mothers are at an increased risk of developing early-onset GBS disease, manifesting within the first week of life. Clinical features of early-onset GBS disease include respiratory distress, fever, lethargy, and poor feeding. Late-onset GBS disease can occur between the second week and several months of life, presenting with symptoms such as meningitis, sepsis, and pneumonia. Prevention strategies involve intrapartum antibiotic prophylaxis for GBS-positive pregnant women, which has significantly reduced the incidence of early-onset disease.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea
Stephanie Maltais, University of Montreal, Canada
Title : E2 ubiquitin-conjugating enzymes regulates dengue virus-2 replication in Aedes albopictus
Xueli Zheng, Southern Medical University, China